CA2440743A1 - Matrix gene expression in chondrogenesis - Google Patents

Matrix gene expression in chondrogenesis Download PDF

Info

Publication number
CA2440743A1
CA2440743A1 CA002440743A CA2440743A CA2440743A1 CA 2440743 A1 CA2440743 A1 CA 2440743A1 CA 002440743 A CA002440743 A CA 002440743A CA 2440743 A CA2440743 A CA 2440743A CA 2440743 A1 CA2440743 A1 CA 2440743A1
Authority
CA
Canada
Prior art keywords
gly
pro
sequence
ala
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002440743A
Other languages
English (en)
French (fr)
Inventor
Rebecca Roubin
Peter Ghosh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sydney
Chondrogenesis Pty Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2440743A1 publication Critical patent/CA2440743A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002440743A 2001-02-15 2002-02-15 Matrix gene expression in chondrogenesis Abandoned CA2440743A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPR3116 2001-02-15
AUPR3116A AUPR311601A0 (en) 2001-02-15 2001-02-15 Matrix gene expression in chondrogenesis
PCT/AU2002/000163 WO2002064625A1 (en) 2001-02-15 2002-02-15 Matrix gene expression in chondrogenesis

Publications (1)

Publication Number Publication Date
CA2440743A1 true CA2440743A1 (en) 2002-08-22

Family

ID=3827137

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002440743A Abandoned CA2440743A1 (en) 2001-02-15 2002-02-15 Matrix gene expression in chondrogenesis

Country Status (8)

Country Link
US (1) US20040157329A1 (https=)
EP (1) EP1370579A4 (https=)
JP (1) JP2004537274A (https=)
AU (1) AUPR311601A0 (https=)
CA (1) CA2440743A1 (https=)
NO (1) NO20033624L (https=)
NZ (1) NZ528202A (https=)
WO (1) WO2002064625A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004026944D1 (de) * 2003-03-28 2010-06-10 Fujifilm Mfg Europe Bv RGD-angereicherte gelatineähnliche Proteine zur Verhinderung der Blutplättchenaggregation
US7318925B2 (en) * 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
CN1838968A (zh) 2003-08-08 2006-09-27 艾伯吉尼斯公司 针对甲状旁腺激素(pth)之抗体和其用途
WO2005106495A1 (en) * 2004-05-04 2005-11-10 Pharmacia & Upjohn Company Llc Procollagen ii biomarkers and methods
US20080082170A1 (en) * 2006-09-29 2008-04-03 Peterman Marc M Apparatus and methods for surgical repair
ES2678211T3 (es) 2012-03-27 2018-08-09 Ventana Medical Systems, Inc. Conjugados de señalización y procedimientos de uso
WO2014093836A1 (en) * 2012-12-13 2014-06-19 University Of Georgia Research Foundation, Inc. Ossification-inducing composition and methods of use thereof
JP2020502056A (ja) * 2016-11-13 2020-01-23 イマジン ファーマ 糖尿病、高血圧および高コレステロール血症を治療するための組成物および方法
US20230210942A1 (en) * 2018-01-09 2023-07-06 Imagine Pharma Llc Methods and compositions for modulating endothelial cell dysfunction
CN113096736B (zh) * 2021-03-26 2023-10-31 北京源生康泰基因科技有限公司 一种基于纳米孔测序的病毒实时自动分析方法及系统
CN113201487A (zh) * 2021-07-06 2021-08-03 广东先康达生物科技有限公司 成软骨细胞培养基及成软骨细胞的培养方法
CN113563458B (zh) * 2021-07-19 2023-07-21 嘉兴恒杰生物制药股份有限公司 一种非变性ii型胶原蛋白的制备方法
JP2024532985A (ja) * 2021-09-22 2024-09-12 イマジン ファーマ、エルエルシー 1型糖尿病患者膵臓組織からインスリンおよびグルカゴン分泌細胞を増殖させるための組成物および方法およびその治療的使用
CN119504941B (zh) * 2024-12-03 2026-01-13 中国海洋大学 一种富含海洋肽钙螯合物的骨健康压片糖果及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080891A (en) * 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US6159464A (en) * 1990-12-20 2000-12-12 University Of Pittsburgh Of The Commonwealth System Of Higher Education Viral vectors to inhibit leukocyte infiltration or cartilage degradation of joints
JP2001512013A (ja) * 1997-08-01 2001-08-21 ジェンセット 前立腺に発現される分泌タンパク質の5’est
US20030144475A1 (en) * 1999-12-06 2003-07-31 Seishi Kato Human protein and cdna

Also Published As

Publication number Publication date
AUPR311601A0 (en) 2001-03-08
EP1370579A4 (en) 2005-05-11
EP1370579A1 (en) 2003-12-17
WO2002064625A1 (en) 2002-08-22
NO20033624L (no) 2003-10-10
US20040157329A1 (en) 2004-08-12
NZ528202A (en) 2005-09-30
JP2004537274A (ja) 2004-12-16
NO20033624D0 (no) 2003-08-14

Similar Documents

Publication Publication Date Title
US6924367B2 (en) Method of modulating tissue growth using Frzb Protein
US20040157329A1 (en) Matrix gene expression in chondrogenesis
EP0643767B1 (en) Osteogenic peptides
JP2002516103A (ja) インターロイキン21およびインターロイキン22
US20110177043A1 (en) Method of improving differentiation of chondrogenic progenitor cells
JP2002502589A (ja) 45個のヒト分泌タンパク質
CA2284131A1 (en) 70 human secreted proteins
JPH04505607A (ja) 骨誘導タンパク
CA2200980C (en) Mammalian receptors for modified low-density lipoprotein
JP2002525112A (ja) 新規dkrポリペプチド
JP2002500035A (ja) 36個のヒト分泌タンパク質
KR100629185B1 (ko) 인간 리조포스파티드산 수용체 물질 및 그 용도
JP2005287515A (ja) 形態形成タンパク質を含むTGF−βスーパーファミリー変異体メンバー
EP0588118B1 (en) Bone-related carboxypeptidase-like protein and process for its production
US7626003B2 (en) Genetically engineered cDNA of rat bcl-x gene and an improved protein
US7049291B2 (en) Isolation and method of using tissue growth-inducing Frzb protein
AU2002233029A1 (en) Matrix gene expression in chondrogenesis
US20030139591A1 (en) Isolation and use of tissue growth-inducing Frzb protein
WO1998001468A1 (en) Chondrocyte proteins
KR101972988B1 (ko) 피불린-1 단백질을 포함하는 줄기세포의 골분화 촉진용 조성물
US20030113869A1 (en) Human FGF gene and gene expression products
CA2444594A1 (en) Sprr1a and axonal regeneration
WO2003070937A1 (fr) Proteine ayant une zone de fixation d'une proteine osteogenique et gene codant pour cette proteine
IL130224A (en) CELL GROWTH AND DIFFERENTIATION REGULATORY AChE PEPTIDE AND USES THEREOF
JPWO2001013951A1 (ja) 軟骨形成促進剤

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued